Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 49 out of 100. Getting a diagnosis

Topic: Amyloid, tau and blood-test diagnosis

This comprehensive review examines the integration of Quantitative Electroencephalography (qEEG) and Artificial Intelligence (AI) in the detection and diagnosis of Alzheimer's Disease (AD). Through systematic analysis of 11 key studies across multiple international databases, we evaluated various AI architectures, including machine learning algorithms and deep learning networks, applied to qEEG data for AD detection. The review encompasses studies with diverse subject populations, ranging from 35 to 890 participants, with mean ages between 66.94 and 74.8 years. Results demonstrate that AI-enhanced qEEG analysis achieves remarkable diagnostic accuracy, with Linear Discriminant Analysis (LDA) reaching 93.18% accuracy and 97.92% Area Under Curve (AUC). Convolutional Neural Networks (CNNs) and Support Vector Machines (SVMs) also showed promising results, with some models achieving up to 100% sensitivity in specific classifications. The integration of multiple data types and advanced feature extraction methods significantly improved diagnostic precision. Geographic diversity in research origins, spanning from Asia to Europe and the Americas, provides robust cross-cultural validation of findings. However, challenges persist in data quality, computational resources, and standardization of methodologies. This review highlights the significant potential of AI-enhanced qEEG as a non-invasive, cost-effective tool for the diagnosis of AD in its prodromal and dementia stages, while also identifying areas requiring further research to optimize its clinical application. These findings suggest that AI-enhanced qEEG analysis could revolutionize AD diagnosis, enabling earlier intervention and improved patient outcomes.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rezaei, S., Asadirad, F., Motamed, A., Kamran, M., Parsa, F., Samimi, H., et al. (2025). Future of Alzheimer's detection: Advancing diagnostic accuracy through the integration of qEEG and artificial intelligence. NeuroImage. https://doi.org/10.1016/j.neuroimage.2025.121373

Vancouver

Rezaei S, Asadirad F, Motamed A, Kamran M, Parsa F, Samimi H, et al. Future of Alzheimer's detection: Advancing diagnostic accuracy through the integration of qEEG and artificial intelligence. NeuroImage. 2025. doi:10.1016/j.neuroimage.2025.121373. PMID: 40675424.

BibTeX

@article{rezaei2025-40675424,
  author  = {Rezaei, Sahar and Asadirad, Farzan and Motamed, Arash and Kamran, Mohammadsadegh and Parsa, Farzaneh and Samimi, Haniyeh and Ghannadikhosh, Parna and Zahmatyar, Mahdi and others},
  title   = {{Future of Alzheimer's detection: Advancing diagnostic accuracy through the integration of qEEG and artificial intelligence}},
  journal = {NeuroImage},
  year    = {2025},
  doi     = {10.1016/j.neuroimage.2025.121373},
  pmid    = {40675424},
  url     = {https://doi.org/10.1016/j.neuroimage.2025.121373}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This review reports that combining qEEG with AI achieved high diagnostic accuracy for detecting Alzheimer's disease in the studies examined. It addresses detection and diagnosis only, and notes ongoing challenges in data quality, computing resources and standardisation; it does not report any treatment or cure.

Study details

How this study scored 49/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 49 of 100.49 of 100 points earned51 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (NeuroImage)
Journal's citation record 4 / 4 NeuroImage: journal h-index 523 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 890 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 8 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.7 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 5.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 1 / 4 Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Hossein Arabi: h-index 47 (OpenAlex, whole career)
Institution's track record 0 / 3 University Hospital of Geneva: institution h-index 635 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40675424)
Free to read 2 / 2 Free to read
Total 49 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Getting a diagnosis

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →